Adopt shares (301122.SZ) to plan to acquire no less than 20% of Pai Peptide Biotech's shares through cash payment

Zhitongcaijing · 1d ago

Zhitong Finance App News, Adopting Shares (301122.SZ) issued an announcement. The company is planning to acquire no less than 20% of Zhejiang Pai Peptide Biotech Co., Ltd. (“Pai Peptide Biotech”) by cash payment. On September 24, 2026, the company and Xing Haiying, Shengzhou Hanyuan Investment Management Partnership (Limited Partnership), Shengzhou Fuding Biotechnology Partnership (Limited Partnership), Shengzhou Zhongxin Investment Management Partnership (Limited Partnership) Management partnership (Limited Partnership) and Peptide Biotech signed a “Letter of Intent to Acquire”.

While steadily developing its original main business, the company is actively exploring the layout of new profit growth points through mergers and acquisitions. Based on the current policy direction of mergers, acquisitions and restructuring regulations to support listed companies to grow bigger and stronger through mergers and acquisitions, the company actively seeks high-quality mergers and acquisitions in the field of big health to improve the layout of the health industry and enhance the company's core competitiveness. The successful implementation of this transaction will help the company integrate high-quality industry resources and achieve synergy effects, thereby creating greater value for the company's shareholders and in line with the company's long-term development and strategic planning.